Biotechnology

Entrada Therapeutics’ mission is to transform the treatment of devastating diseases and improve patients' quality of life by developing intracellular biologics.

Keros is dedicated to discovery and development of novel therapeutics for hematological and musculoskeletal disorders.

We are the independent body in the UK representing the diversity of medical science. Our mission is to advance biomedical and health research and its translation into benefits for society. We are working to secure a future in which: - UK and global health is improved by the best research. - UK lea

Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.

Frontier Medicines, located in South San Francisco, CA and Boston, MA, is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable.

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.

Century Therapeutics is harnessing the power of stem cells to develop curative cell therapy products for cancer.

Alimentiv Health Trust provides clinical trials, central image management, and precision medicine services to the pharmaceutical and biotechnology industries.

Unlocking the promise of cell & gene therapy

Embark offers the most comprehensive, most accurate dog DNA test on the market. An Embark dog DNA test gives pet owners information about their dog’s breed, ancestry, health, and more — all with just a simple cheek swab.

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products inlcude, among others, MCLA-...

MMS is a CRO focused on clinical development, medical writing, programming, statistics, PV, and regulatory submissions for pharma and biotech.

Caribou Biosciences is a leading clinical-stage CRISPR genome editing biotechnology company founded by pioneers of CRISPR biology and located in Berkeley, CA. The company is developing an internal pipeline of off-the-shelf, genome-edited CAR-T and natural killer (NK) cell therapies.

Associates of Cape Cod is a biotechnology firm that offers endotoxin detection reagents and contract testing services.

Developing next generation technologies for precision medicine and drug discovery.

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues.

Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chi...

Isotopen Technologien München is a privately held biotechnology and radiopharmaceutical group of companies.

Frontier Science renders a wide range of research services with clinical trials to pharmaceutical companies and other organizations.

Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer c

Guided by our powerful AI capabilities, Terray leverages vast high-quality data to optimize the path from discovery to transformative therapeutics.

MassBio’s mission is to advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives.

Dragonfly Therapeutics is a discovery-stage company developing drugs to stimulate immune responses against cancer.

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

SCHOTT MINIFAB is ISO 9001 & ISO 13485 certified, offering contract design, development and manufacturing of microfluidic consumables and high-density microarrays for diagnostic and life science research. Enabling product developers to get their innovation to market faster and more efficiently. We

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectiv

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals.

MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.

TMRW safeguards the world’s most precious cells for life. The TMRW platform revolutionizes the management, identification, and storage of fertility cells, replacing the manual and analog methods that have remained largely unchanged since IVF was first used in animal husbandry more than 50 years ago.

Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In

Vizgen is the life sciences company developing the next generation of Spatially Resolved Transcriptomics.

Brazilian pharmaceutical company focused on the swine and poultry health.

CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies.

KCR is a clinical development solutions provider creating value for biotechnology and pharmaceutical organizations. Founded in 1997, our expert teams support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting, and Placement. KCR operates

A-Alpha Bio is a provider of cell-based tools for quantitative and high-throughput measurements of protein interactions.

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Precision BioSciences utilizes its proprietary ARCUS Genome Editing method to overcome cancers, cure genetic diseases, and enable development of safer food.

Allakos is developing therapeutic antibodies that that selectively target eosinophils and mast cells, cells that play a significant role in many diseases

Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Bioscience

Biosynth specializes in antibody packages and custom peptide synthesis services for small and large scale industries

Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on

Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Newlight Technologies is a biotechnology company producing advanced sustainable materials.

Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of genetically driven diseases.

Material Innovation Initiative is a nonprofit that accelerates the availability of high-quality, high-performance, animal-free, and environmentally preferred materials.

SCIEX helps to improve the world by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry ha

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine.